Fmr LLC Intellia Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,520,548 shares of NTLA stock, worth $37.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,520,548

Previous 1,590,302 4.39%

Holding current value

$37.9 Million

Previous $11.3 Million 26.13%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.28 - $9.67 $438,055 - $674,521	-69,754 Reduced 4.39%	1,520,548 $14.3 Million
Q1 2025 May 12, 2025	BUY	$7.11 - $12.8 $2.4 Million - $4.32 Million	337,463 Added 26.94%	1,590,302 $11.3 Million
Q4 2024 Feb 13, 2025	SELL	$11.41 - $21.09 $12.4 Million - $22.9 Million	-1,086,683 Reduced 46.45%	1,252,839 $14.6 Million
Q3 2024 Nov 13, 2024	BUY	$19.72 - $27.36 $2.19 Million - $3.04 Million	111,104 Added 4.99%	2,339,522 $48.1 Million
Q2 2024 Aug 13, 2024	BUY	$20.02 - $27.22 $441,961 - $600,908	22,076 Added 1.0%	2,228,418 $49.9 Million
Q1 2024 May 13, 2024	BUY	$23.82 - $32.8 $24.3 Million - $33.4 Million	1,019,739 Added 85.94%	2,206,342 $60.7 Million
Q4 2023 Feb 13, 2024	SELL	$23.16 - $32.34 $7.1 Million - $9.91 Million	-306,425 Reduced 20.52%	1,186,603 $36.2 Million
Q3 2023 Nov 13, 2023	SELL	$31.62 - $45.78 $533,903 - $772,995	-16,885 Reduced 1.12%	1,493,028 $47.2 Million
Q2 2023 Aug 11, 2023	BUY	$34.58 - $46.03 $10.5 Million - $14 Million	304,256 Added 25.24%	1,509,913 $61.6 Million
Q1 2023 May 11, 2023	SELL	$33.3 - $44.82 $40.5 Million - $54.5 Million	-1,216,295 Reduced 50.22%	1,205,657 $44.9 Million
Q4 2022 Feb 13, 2023	SELL	$33.21 - $62.69 $6.8 Million - $12.8 Million	-204,801 Reduced 7.8%	2,421,952 $84.5 Million
Q3 2022 Nov 10, 2022	SELL	$53.92 - $71.7 $36.6 Million - $48.7 Million	-678,653 Reduced 20.53%	2,626,753 $147 Million
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $19.6 Million - $38.9 Million	510,481 Added 18.26%	3,305,406 $171 Million
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $63.1 Million - $129 Million	-1,082,848 Reduced 27.92%	2,794,925 $203 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $70.3 Million - $96.5 Million	697,405 Added 21.93%	3,877,773 $459 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $59.8 Million - $79.8 Million	451,566 Added 16.55%	3,180,368 $427 Million
Q2 2021 Aug 13, 2021	BUY	$60.88 - $161.91 $166 Million - $442 Million	2,728,802 New	2,728,802 $442 Million

Others Institutions Holding NTLA

# of Institutions

334

Shares Held

97M

Call Options Held

1.66M

Put Options Held

1.03M

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.89B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account